The company expired its plan on July 24, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
31.26 CNY | +1.13% | +8.50% | -4.29% |
Apr. 23 | Salubris Pharmaceuticals' Q1 Profit Falls 5% Despite 23% Rise in Operating Income | MT |
Apr. 23 | Salubris Pharmaceuticals to Raise Capital of US Unit by $35 Million | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.29% | 4.66B | |
+19.62% | 43.78B | |
+20.44% | 21.89B | |
+10.86% | 14.45B | |
+13.07% | 13.63B | |
+37.46% | 11.49B | |
-8.59% | 6.85B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+8.46% | 5.06B |
- Stock Market
- Equities
- 002294 Stock
- News Shenzhen Salubris Pharmaceuticals Co., Ltd.
- Shenzhen Salubris Pharmaceuticals Co., Ltd.'s Equity Buyback announced on July 25, 2021, has expired with 23,457,523 shares, representing 2.12% for CNY 602.01 million.